skip to Main Content

Gallstone Disease Shown to be Strong Predictor of Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Patients with pancreatic ductal adenocarcinoma (PDAC) were six times more likely to have had gallstone disease within the year prior to diagnosis than non-cancer patients, suggesting gallstones could be a warning sign for this aggressive and deadly cancer, according to research to be presented at Digestive Disease Week® (DDW) 2022.  PDAC is the most common pancreatic cancer, accounting for more than 90% of cases, and it is often fatal because it tends to be diagnosed in late stages.

“Pancreatic cancer can be difficult to diagnose and then chances of survival are slim. Our findings suggest that gallstone disease may be a way to better diagnose this type of cancer – meaning we could save more lives,” said Marianna Papageorge, MD, lead researcher on the study and research fellow at Boston Medical Center. Read more . . . 


Back To Top